Invention Grant
- Patent Title: CDK inhibitors and their use as pharmaceuticals
-
Application No.: US17018005Application Date: 2020-09-11
-
Publication No.: US11673893B2Publication Date: 2023-06-13
- Inventor: Liang Lu , Rupa Shetty , Andrew Paul Combs , Chaofeng Dai , Raul Andrew Leal , Klare Lazor Bersch
- Applicant: Prelude Therapeutics Incorporated
- Applicant Address: US DE Wilmington
- Assignee: Prelude Therapeutics Incorporated
- Current Assignee: Prelude Therapeutics Incorporated
- Current Assignee Address: US DE Wilmington
- Agency: BakerHostetler
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D401/08 ; C07D417/14 ; C07D471/04 ; C07D401/14 ; C07D417/08 ; C07D413/14 ; A61P35/00 ; C07D401/04 ; C07D405/14 ; C07D417/04 ; C07D498/04
Abstract:
The disclosure is directed to, in part, to CDK inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation.
Public/Granted literature
- US20210070761A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS Public/Granted day:2021-03-11
Information query
